DS
About
Dr. Slee currently serves as the Vice President of Research & Development of ACTUS Biotechnologies and its two subsidiaries, Convoy Therapeutics, Inc. and EnduRx Pharmaceuticals, Inc. Dr. Slee has over two decades of experience in research and development in the biotechnology and pharmaceutical sectors. Dr. Slee began her career at Ontogen Corporation, followed by Neurocrine Biosciences and subsequently co-founded Aspyrian Therapeutics and CendR Therapeutics. Dr. Slee completed her Ph.D. at the University of Exeter and performed her postdoctoral research at The Scripps Research Institute in La Jolla, CA.
Position in the VCSift Database
- • 1 investors hold the VP of Research and Development role in VCSift. Deborah Slee is one of them.
- • 829 investors are based in San Diego, California, United States.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Location
- San Diego, US
Contact Information
linkedin.com/in/••••••••
Find more investors like Deborah
Search Investors